← Eichor
Condition: Red Blood Cell Disorder Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Red Blood Cell Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Variation of Echocardiographic Parameters After Red Blood Cell Transfusion in Emergency Department Anemic Patients
NA · 1 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT06060639Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functi
NA · 1 location(s) · University of Washington · NCT06710418Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT03685721Transfusion in Lower Risk MDS Patients: Predictors of Adequacy of Transfusion and Quality of Life in Lower Risk MDS
Phase N/A · 1 location(s) · Fundación para la Investigación Biosanitaria del Principado · NCT06614595RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)
Phase N/A · 1 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT06213402Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)
Phase N/A · 1 location(s) · Northwell Health · NCT07186179A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis
Phase 2 · 46 location(s) · Takeda · NCT05037760Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery a
Phase 1 · 2 location(s) · Jose Cancelas · NCT07446647Role of Red Blood Cells in Cardiovascular Disease
Phase N/A · 1 location(s) · Karolinska Institutet · NCT07151222Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Si
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT06944067Folic Acid Salt Study (FISFA Zambia)
NA · 2 location(s) · University of Alabama at Birmingham · NCT06734611Biomarkers in Patients With Anemia-Induced Thrombocytopenic Bleeding
NA · 1 location(s) · Donald Arnold · NCT06947044Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Phase 2 · 26 location(s) · Celgene · NCT04143724Pathophysiological Explorations of Red Blood Cells
Phase N/A · 25 location(s) · Imagine Institute · NCT03541525Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling
Phase 2 · 1 location(s) · University of Calgary · NCT03214354Cardiopulmonary Bypass Induced Red Blood Cell Lysis
Phase N/A · 1 location(s) · University of Maryland, Baltimore · NCT05189262Use of Epoetin Alfa and Iron Derisomaltose in Treatment of Anemia in Patients With Sepsis or Septic Shock: a Randomized
Phase 4 · 1 location(s) · Piotr Czempik · NCT06670963A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myel
Phase 3 · 156 location(s) · Takeda · NCT07422480Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Phase N/A · 1 location(s) · Paul Szabolcs · NCT04528355The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion
NA · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT06012760Diamond Blackfan Anemia Registry (DBAR)
Phase N/A · 1 location(s) · Northwell Health · NCT00106015Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant t
Phase 2 · 23 location(s) · Associazione Qol-one · NCT05924100National Exhaustive Cohort of Hereditary Stomatocytoses and Other Channelopathies Affecting the Red Blood Cell
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04778657Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion
NA · 1 location(s) · Hemanext · NCT06685848A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in
Phase 1/Phase 2 · 8 location(s) · Regeneron Pharmaceuticals · NCT07187401Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO
NA · 12 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06560164Blood Warming in Preterm Infants to Decrease Hypothermia
NA · 1 location(s) · University of South Carolina · NCT05170633National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852European Rare Blood Disorders Platform (ENROL)
Phase N/A · 1 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT06250595Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies
EARLY_Phase 1 · 1 location(s) · Westlake Therapeutics · NCT05707325
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.